.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Cipla
Mallinckrodt
Queensland Health
Express Scripts
Dow
Deloitte
Teva
Cantor Fitzgerald
Chinese Patent Office

Generated: June 29, 2017

DrugPatentWatch Database Preview

CEREBYX Drug Profile

« Back to Dashboard

What is the patent landscape for Cerebyx, and what generic Cerebyx alternatives are available?

Cerebyx is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in CEREBYX is fosphenytoin sodium. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the fosphenytoin sodium profile page.

Summary for Tradename: CEREBYX

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list10
Clinical Trials: see list1
Patent Applications: see list883
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEREBYX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
CEREBYX
fosphenytoin sodium
INJECTABLE;INJECTION020450-001Aug 5, 1996APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CEREBYX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke Davis
CEREBYX
fosphenytoin sodium
INJECTABLE;INJECTION020450-001Aug 5, 19964,260,769► Subscribe
Parke Davis
CEREBYX
fosphenytoin sodium
INJECTABLE;INJECTION020450-001Aug 5, 19964,925,860► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Cantor Fitzgerald
Mallinckrodt
Federal Trade Commission
Citi
Medtronic
Deloitte
QuintilesIMS
Covington
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot